3D Cell Culture Market is Growing at Significant Rate, 2028: Grand View Research Inc.

 3D Bioprinting Market Growth & Trends

The global 3D bioprinting market size is expected to reach USD 4.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.8% from 2021 to 2028. Rising cases of COVID-19 and increasing prevalence of chronic diseases are some of the major factors contributing towards market growth.

The COVID-19 epidemic is ever increasing since it was first identified in China in December 2019. Until January 12, 2021, more than 91.5 million cases of COVID-19 were reported globally, with more than 1,956,880 deaths, across the globe. This pandemic has fast tracked the development of vaccine and drug testing. There are currently more than 50 COVID-19 vaccine candidates in trials.

In the meantime, various 3D bioprinting companies are focused on research and development of artificial tissues. With the help of U-FAB, and other bioprinting technologies, CLECELL company has created respiratory epithelium artificial tissue which will help to prevent infection and tissue injury through the use of the mucociliary elevator. This pandemic has not only affected the well-being of people, but has also affected the economy, and various other healthcare infrastructures worldwide. This has severely disrupted the medical devices and pharmaceutical supply chains across the world. In such critical situation, various 3D bioprinting companies have created a global movement to supply emergency medical equipment such as ventilators, and personal protection equipment (PPE), to the healthcare workers.

North America held the highest share of the market, accounting for about 32.4% of the market share in 2020. Increasing adoption of 3D bioprinting for the production of medical products is expected to be one of the major factors contributing to market growth in this region. Whereas, Asia Pacific is anticipated to witness technological developments in pharmaceutical and biopharmaceutical sectors.

Request a free sample copy or view report summary: 3D Bioprinting Market Report

3D Bioprinting Market Report Highlights

• The medical segment accounted for the largest revenue share of 36.2% in 2020 due to the increasing investment made in R&D
• The magnetic levitation segment is anticipated to witness the highest CAGR of 17.0% over the forecast period due to technological development and increasing adoption of magnetic levitation technique by various innovators
• North America dominated the market in 2020 and accounted for the largest revenue share of 32.4%. Growing government expenditure on healthcare industry is one of the major factors driving the market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-3d-bioprinting-market

3D Bioprinting Market Segmentation

Grand View Research has segmented the global 3D bioprinting market on the basis of technology, application, and region:

3D Bioprinting Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Inkjet-based
• Magnetic Levitation
• Syringe-based
• Laser-based
• Others

3D Bioprinting Application Outlook (Revenue, USD Million, 2016 - 2028)

• Medical
  • Tissue and organ generation
  • Medical pills
  • Prosthetics and implants
• Dental
• Biosensors
• Consumer/Personal Product Testing
• Bioinks
• Food and Animal Product

3D Bioprinting Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Columbia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of 3D Bioprinting Market

• Envisiontec, Inc.
• Organovo Holdings, Inc.
• Inventia Life Science PTY LTD
• Poietis
• Vivax Bio, LLC
• Allevi
• Cyfuse Biomedical K.K.
• 3D Bioprinting Solutions
• Cellink Global
• Regemat 3D S.L.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

3D Bioprinting Market Analysis ,Industry Growth And Future Scope: Grand View Research Inc.

 3D Bioprinting Market Growth & Trends

The global 3D bioprinting market size is expected to reach USD 4.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.8% from 2021 to 2028. Rising cases of COVID-19 and increasing prevalence of chronic diseases are some of the major factors contributing towards market growth.

The COVID-19 epidemic is ever increasing since it was first identified in China in December 2019. Until January 12, 2021, more than 91.5 million cases of COVID-19 were reported globally, with more than 1,956,880 deaths, across the globe. This pandemic has fast tracked the development of vaccine and drug testing. There are currently more than 50 COVID-19 vaccine candidates in trials.

In the meantime, various 3D bioprinting companies are focused on research and development of artificial tissues. With the help of U-FAB, and other bioprinting technologies, CLECELL company has created respiratory epithelium artificial tissue which will help to prevent infection and tissue injury through the use of the mucociliary elevator. This pandemic has not only affected the well-being of people, but has also affected the economy, and various other healthcare infrastructures worldwide. This has severely disrupted the medical devices and pharmaceutical supply chains across the world. In such critical situation, various 3D bioprinting companies have created a global movement to supply emergency medical equipment such as ventilators, and personal protection equipment (PPE), to the healthcare workers.

North America held the highest share of the market, accounting for about 32.4% of the market share in 2020. Increasing adoption of 3D bioprinting for the production of medical products is expected to be one of the major factors contributing to market growth in this region. Whereas, Asia Pacific is anticipated to witness technological developments in pharmaceutical and biopharmaceutical sectors.

Request a free sample copy or view report summary: 3D Bioprinting Market Report

3D Bioprinting Market Report Highlights

• The medical segment accounted for the largest revenue share of 36.2% in 2020 due to the increasing investment made in R&D
• The magnetic levitation segment is anticipated to witness the highest CAGR of 17.0% over the forecast period due to technological development and increasing adoption of magnetic levitation technique by various innovators
• North America dominated the market in 2020 and accounted for the largest revenue share of 32.4%. Growing government expenditure on healthcare industry is one of the major factors driving the market

Access Press Release@ https://www.grandviewresearch.com/press-release/global-3d-bioprinting-market

3D Bioprinting Market Segmentation

Grand View Research has segmented the global 3D bioprinting market on the basis of technology, application, and region:

3D Bioprinting Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Inkjet-based
• Magnetic Levitation
• Syringe-based
• Laser-based
• Others

3D Bioprinting Application Outlook (Revenue, USD Million, 2016 - 2028)

• Medical
  • Tissue and organ generation
  • Medical pills
  • Prosthetics and implants
• Dental
• Biosensors
• Consumer/Personal Product Testing
• Bioinks
• Food and Animal Product

3D Bioprinting Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Columbia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of 3D Bioprinting Market

• Envisiontec, Inc.
• Organovo Holdings, Inc.
• Inventia Life Science PTY LTD
• Poietis
• Vivax Bio, LLC
• Allevi
• Cyfuse Biomedical K.K.
• 3D Bioprinting Solutions
• Cellink Global
• Regemat 3D S.L.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

In Vitro Diagnostics Market Growth in the Coming Years

 In Vitro Diagnostics Market Growth & Trends

The global in vitro diagnostics market size is expected to reach USD 113.9 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 4.5% from 2021 to 2027. The growth is driven by the growing geriatric population and technological advancements in diagnostics that are supporting its adoption.

Technological advancements in terms of accuracy, portability, and cost-effectiveness are expected to be one of the high impact rendering drivers of this market. For instance, in June 2017, Agena Bioscience launched the MassARRAY system integrated with CHIP Prep Module in Europe. The system was marketed as a CE-IVD product under Directive 98/79/EC. Moreover, Real-Time Polymerase Chain Reaction (qPCR) is one of the fastest-growing application segments of the in vitro diagnostics (IVD) market.

The IVD market is highly competitive in nature. Consequently, manufacturers are required to improvise products in terms of specificity, accuracy, precision, speed, and other parameters, in order to gain an advantage over previously marketed products.

A steady rise in consumer awareness about diagnosing infectious diseases and increasing disease prevalence, especially in developing and under-developed countries, are driving the market penetration of the products. For instance, in February 2019, Abbott received CE Mark for DETERMINE HBSAG 2 test for detection and diagnosis of hepatitis B surface antigen.

Organizations promote funding to support R&D and product development exercises pertaining to clinical diagnostics. For instance, Vela Diagnostics received USD 225,000 as Biomedical Advanced Research and Development Authority (BARDA) fund to develop COVID-19 tests. Moreover, the introduction of the American Health Care Act of 2017 is expected to improve the healthcare of the U.S. Rising government initiatives pertaining to the importance of IVD will fuel market growth.

The presence of effective technologies such as molecular diagnostics is expected to reduce the threat of substitutes. Moreover, their contribution in the field of genetic testing is of paramount importance and, therefore, experience a low threat of substitutes. However, high prices of these tests are expected to encourage patients to shift to external substitutes.

Major players in the market are Roche Diagnostics; Becton Dickinson; Abbott Laboratories; Siemens; and bioMerieux, which are well-established. Therefore, local companies and new organizations have little scope to enter the market and ensure sustainability. However, companies such as Danaher Corporation and Hologic have successfully excelled in the market through mergers and acquisitions. The seed capital required is high.

Request a free sample copy or view report summary: In Vitro Diagnostics Market Report 

In Vitro Diagnostics Market Report Highlights

• Molecular diagnostics is expected to witness the fastest growth over the forecast period
• High use of reagents in IVD testing, high demand for over-the-counter diagnostic tests, and increase in adoption of these tests in nonmedical facilities, such as home, are some of the factors that are driving the growth, providing it a clinical advantage over other IVD tests
• Reagents held the largest market share in 2020 owing to the increasing demand for genetic testing and availability of technologically advanced cancer diagnostic tests in countries with unmet clinical needs, such as India and Middle East & Africa
• The growing availability of CE-IVD certified kits globally to diagnose and screen patients during epidemic situations is expected to boost the growth of reagents and instruments segments
• Key players are updating their range of testing options for qPCR instruments by undertaking R&D initiatives for the development of kits that target emerging diseases, or by entering into agreements with other kit manufacturing companies

Access Press Release@ https://www.grandviewresearch.com/press-release/global-in-vitro-diagnostics-market

In Vitro Diagnostics Market Segmentation

Grand View Research has segmented the global in-vitro diagnostics market based on the product, technology, application, end-use, and region:

In Vitro Diagnostics Product Outlook (Revenue, USD Million, 2016 - 2027)

• Instruments
• Reagents
• Services

In Vitro Diagnostics Technology Outlook (Revenue, USD Million, 2016 - 2027)

• Immunoassay
  • Instruments
  • Reagents
  • Services
• Hematology
  • Instruments
  • Reagents
  • Services
• Clinical Chemistry
  • Instruments
  • Reagents
  • Services
• Molecular Diagnostics
  • Instruments
  • Reagents
  • Services
• Coagulation
  • Instruments
  • Reagents
  • Services
• Microbiology
  • Instruments
  • Reagents
  • Services
• Others
  • Instruments
  • Reagents
  • Services

In Vitro Diagnostics Application Outlook (Revenue, USD Million, 2016 - 2027)

• Infectious Disease
• Diabetes
• Oncology
• Cardiology
• Nephrology
• Autoimmune Disease
• Drug testing
• Others

In Vitro Diagnostics End-use Outlook (Revenue, USD Million, 2016 - 2027)

• Hospitals
• Laboratories
• Home Care
• Others

In Vitro Diagnostics Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Singapore
  • Australia
• Latin America
  • Brazil
  • Argentina
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of In Vitro Diagnostics Market

• Abbott
• Danaher
• bioMérieux SA
• Bio-Rad Laboratories, Inc.
• Becton, Dickinson and Company
• Siemens Healthineers AG
• QIAGEN
• Quidel Corporation
• Hoffmann-La Roche AG
• Sysmex Corporation
• Charles River Laboratories International, Inc.
• Quest Diagnostics
• Agilent Technologies

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Biosensors Market Expected To Propel Industry Growth By Size ,Share And Forecast To 2028: Grand View Research Inc.

 

Biosensors Market Growth & Trends

The global biosensors market size is anticipated to reach USD 41.8 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.9% from 2021 to 2028. The rising prevalence of chronic conditions such as diabetes and obesity and the growing demand for early and accurate detection of any associated condition are the key driving factors for the market.

As per the WHO report, in 2016 over 1.9 billion individuals were overweight, out of which nearly 650.0 million were obese. This has increased the sales of testing and monitoring kits used as medical sensors in the home as well as healthcare settings, thus, boosting the market growth.

Furthermore, the outbreak of COVID-19 has drastically spurred the demand for point-of-care testing devices. FDA is giving fast-track approvals to the companies owing to the shortage of these devices globally. For instance, in May 2020, Philips secured 510k FDA clearance for its wearable biosensor, which helps in managing confirmed and suspected cases of COVID-19 in hospitals, promoting biosensors technology and product development.

Moreover, rapid technological advancements are expected to be a significant factor for market growth over the forecast period. For instance, in June 2020, Abbott received the U.S. FDA clearance for its next-generation, integrated glucose monitor system- FreeStyle Libre 2 intended to measure diabetes in individuals aged 4 years and above and has an optional real-time alarm.               

Request a free sample copy or view report summary: Biosensors Market Report

Biosensors Market Report Highlights

• On the basis of application, the medical segment dominated the market in 2020 with a revenue share of 66.6%. The device is considered an essential tool in the detection and monitoring of a wide range of medical conditions, such as diabetes and cancer
• Based on technology, the electrochemical segment dominated the market in 2020 with a revenue share of 70.9% owing to its widespread applications for analysis in biochemical and biological processes
• The home healthcare diagnostics segment is expected to witness the fastest growth rate over the forecast period owing to the high prevalence of chronic disease globally
• North America dominated the market in 2020 with a revenue share of 39.9% owing to the presence of a highly developed healthcare infrastructure and favorable reimbursement policies in this region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-biosensors-market

Biosensors Market Segmentation

Grand View Research has segmented the global biosensors market on the basis of application, technology, end-use, and region:

Biosensors Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Thermal
• Electrochemical
• Piezoelectric
• Optical

Biosensors Application Outlook (Revenue, USD Million, 2016 - 2028)

• Medical
  • Cholesterol
  • Blood Glucose
  • Blood Gas Analyzer
  • Pregnancy Testing
  • Drug Discovery
  • Infectious Disease
• Food Toxicity
• Bioreactor
• Agriculture
• Environment
• Others

Biosensors End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Home Healthcare Diagnostics
• PoC Testing
• Food Industry
• Research Laboratories
• Security and Biodefense

Biosensors Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Belgium
  • Switzerland
  • Netherlands
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Indonesia
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Turkey

List of Key Players of Biosensors Market

• AZUR Environmental
• Abbott Laboratories
• Biosensor BV
• Bayer AG
• Cranfield Biotechnology Centre
• Pinnacle Technologies Inc.
• DuPont Biosensor Materials
• Ercon, Inc.
• EG & IC Sensors, Inc.
• Johnson & Johnson
• Innovative Biosensors Inc.
• LifeScan, Inc.
• Strategic Diagnostics
• Sysmex Corporation
• Molecular Devices Corp.
• QTL Biosystems
• Roche Diagnostics

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Biotechnology Market is Expected to Enhance $2.44 Trillion Revenue By 2028: Grand View Research Inc.

 

Biotechnology Market Growth & Trends

The global biotechnology market size is expected to reach USD 2.44 trillion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 15.83% from 2021 to 2028. The factors driving the market include favorable government policies, the launch of new and advanced products, robust investment in the biotechnology sector, and rising demand for synthetic biology.

Robust funding through alliance investment in start-up biotechnology companies for adopting new and advanced products is contributing to market growth. For instance, in February 2021, Illumina, Inc. invested in nine new genomics companies through Illumina Accelerator in 4 start-ups in the U.K. and 5 start-ups in the U.S. The companies include MultiplAI Health LTD.; BiotaX Labs LTD.; Mitra Bio Limited; Broken String Biosciences Limited; Flightpath Biosciences, Inc.; Doloromics Inc.; Oshun Medical Inc.; Parallel Health Inc.; and Rubik Therapeutics, Inc. Illumina Accelerator is an initiative through which selected startups can access to seed investment, genomics expertise, and Illumina sequencing systems and reagents and seek business guidance.

The bioinformatics application segment is expected to expand at the fastest CAGR from 2021 to 2028 owing to the increasing adoption of these tools for analyzing complex sequencing data. By technology, nanobiotechnology is expected to expand at a lucrative growth rate of 16.8% over the forecast period owing to the growing focus on nanotechnologies for efficient drug delivery and increasing research using this technology.

Supportive government initiatives are significantly contributing to market growth. For instance, in September 2020, the Government of India supported research institutes in agriculture biotechnology, including organic farming. Since the last 3 years, around USD 42.67 million had been invested to support this endeavor.

Moreover, the emergence of the SARS-COV-2 infection is driving the market. Companies are developing new solutions for combating the pandemic situation. For instance, in December 2020, Thermo Fisher Scientific Inc. announced CE-marking for TaqPath COVID-19 that can be used to perform in-vitro diagnosis of SARS-CoV-2, respiratory syncytial virus (RSV) A/B, and influenza A/B infections. The new kit will help in the detection and differentiation between diseases that have similar clinical symptoms.

Request a free sample copy or view report summary: Biotechnology Market Report

Biotechnology Market Report Highlights

• The health application segment accounted for the largest share of 48.64% in 2020 owing to the COVID-19 impact, prevalence of diseases, increasing focus on the development of regenerative medicines, and improving healthcare infrastructure
• The DNA sequencing technology segment held the second-largest share in 2020 owing to its growing penetration in the development of precision medicines
• North America held the largest share of 44.19% in 2020. Companies operating in the region are launching advanced solutions to cater to the needs of the biotechnology industry
• For instance, in February 2021, Waters Corporation launched Waters ACQUITY PREMIER Solution. It is a next-generation liquid chromatography solution for improving analytical data quality
• Asia Pacific is expected to expand at the fastest CAGR of 16.8% from 2021 to 2028 owing to favorable government initiatives and changes in drug approval regulations in India and China

Access Press Release@ https://www.grandviewresearch.com/press-release/global-biotechnology-market

Biotechnology Market Segmentation

Grand View Research has segmented the global biotechnology market on the basis of technology, application, and region:

Biotechnology Technology Outlook (Revenue, USD Billion, 2017 - 2028)

• Nanobiotechnology
• Tissue Engineering And Regeneration
• DNA Sequencing
• Cell-based Assays
• Fermentation
• PCR Technology
• Chromatography
• Others

Biotechnology Application Outlook (Revenue, USD Billion, 2017 - 2028)

• Health
• Food & Agriculture
• Natural Resources & Environment
• Industrial Processing
• Bioinformatics
• Others

Biotechnology Regional Outlook (Revenue, USD Billion, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • Spain
  • France
  • Italy
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Biotechnology Market

• AstraZeneca
• Gilead Sciences, Inc.  
• CELGENE CORPORATION
• Biogen
• Abbott
• Amgen Inc.
• Novo Nordisk A/S
• Merck & Co.
• Johnson & Johnson Services, Inc.
• Novartis AG
• Sanofi
• Hoffmann-La Roche Ltd.
• Pfizer, Inc.
• Lonza

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Automotive Smart Display Market to Penetrate Untapped Regions During 2021 to 2028: Grand View Research Inc.

 Automotive Smart Display Market Growth & Trends

The global automotive smart display market size is expected to reach USD 16.98 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.2% from 2021 to 2028. The growing demand for advanced safety features, automotive and cockpit electronics, and semi-autonomous and autonomous vehicles is expected to drive the market. The increasing demand for improved in-vehicle experience and the changing consumer buying behavior, along with the growth of luxury, premium, and high-end cars worldwide, are also expected to fuel the market demand over the forecast period.

The surge in demand for vehicle navigation and connectivity system in the automotive sector led to a growth in the usage of automotive visualization technology. The visualization technology has played a significant role in the advancement of the cockpit technology, which has led to the incorporation of interactive and smart displays in several vehicles launched by prominent automakers, such as Jaguar Land Rover, Mercedes-Benz, Volkswagen, Audi, and BMW. Moreover, the technology is gaining prominence among automotive display suppliers with an uptick in demand for automotive in-vehicle infotainment solutions as well as display solutions. An increase in the sales of passenger vehicles equipped with smart displays and in-vehicle infotainment systems, coupled with features such as navigation, driver assistance, and real-time traffic monitoring, is expected to bolster the market growth over the forecast period.

Asia Pacific held the largest share in 2020 owing to the presence of several key players, such as Panasonic Corporation (Japan), Yazaki (Japan), and Nippon Seiki (Japan) in the region. The region is characterized by the presence of developed nations such as Japan and South Korea, along with emerging economies such as China and India. In recent years, the region has emerged as a hub for automobile production.

Request a free sample copy or view report summary: Automotive Smart Display Market Report

Automotive Smart Display Market Report Highlights

• In terms of display size, the greater than 10" size segment is expected to register the highest CAGR of 9.2% from 2021 to 2028 owing to the increase in the number of semi-autonomous, autonomous, and electric cars
• Based on display technology, the TFT-LCD segment dominated the market in 2020 and is anticipated to maintain its lead the forecast period
• By application, the center stack segment accounted for the largest revenue share of over 40.0% in 2020. Technological developments in self-driving and connected cars are expected to propel the demand for center stack displays in vehicles
• Asia Pacific accounted for the largest revenue share in 2020. This is attributed to increased production and sales of passenger vehicles in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-automotive-smart-display-market

Automotive Smart Display Market Segmentation

Grand View Research has segmented the global automotive smart display market on the basis of display size, display technology, application, and region:

Automotive Smart Display Size Outlook (Revenue, USD Billion, 2016 - 2028)

• Less than 5''
• 5''- 10''
• Greater than 10''

Automotive Smart Display Technology Outlook (Revenue, USD Billion, 2016 - 2028)

• LCD
• TFT-LCD
• OLED
• Others

Automotive Smart Display Application Outlook (Revenue, USD Billion, 2016 - 2028)

• Digital Instrument Cluster
• Center Stack
• Head-up Display (HUD)
• Rear Seat Entertainment

Automotive Smart Display Regional Outlook (Revenue, USD Billion, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa

List of Key Players of Automotive Smart Display Market

• Alps Alpine Co., Ltd.
• Continental AG
• Denso Corporation
• Hyundai Mobis
• Nippon Seiki Co., Ltd.
• Panasonic Corporation
• Pioneer Corporation
• Robert Bosch GmbH
• SAMSUNG (HARMAN International)
• Visteon Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Europe, Middle East & Africa Outdoor Candle Market Report by Opportunity, Demand, recent trends, Major Driving Factors and Business Growth Strategies

 Europe, Middle East & Africa Outdoor Candle Market Growth & Trends

The Europe, Middle East & Africa outdoor candle market size is anticipated to reach USD 624.7 million by 2028, registering a CAGR of 3.9% over the forecast years, according to a new report by Grand View Research, Inc. Outdoor candles have a great significance in celebrations, religious ceremonies, get-togethers, and festivals. They not only provide lighting and create a beautiful ambiance for the festival season but can also have a calming effect on the mind. According to a blog post by Affiliate UNguru, 35% of all candle sales take place during Christmas. In addition, theme-based outdoor parties, events, and weddings have been contributing to the product demand.

Over the past few years, consumers have been gaining interest in home gardens, patio constructions, and creating a green and comfortable outdoor atmosphere that can be used for outdoor cooking and partying. This trend also presents a lucrative growth opportunity for the market in the residential sector. Moreover, a variety of products containing various essential oils can help in keeping bugs and mosquitoes at bay, which also boosts the overall demand in residential as well as commercial applications.

Many manufacturers are focusing on importing candles from countries, such as China, India, and Vietnam, due to low product prices. As per the European Candle Association, imports from China and other low-cost countries, such as India or Vietnam, have witnessed an increase since antidumping duties were stopped four years ago.

According to the European Commission, in 2018, the import of candles from non-EU countries came mainly from China (€237 million, or 66% of extra-EU imports of candles), the United States (€61 million, 17%), and Vietnam (€24 million, 7%), followed by India (€16 million, 4%), Switzerland and Ukraine (each €4 million, 1%), the Dominican Republic (€3 million, 1%), and Thailand and Hong Kong (each €2 million, 1%). Almost two-thirds of EU candle exports went to three countries namely, Switzerland (€43 million, or 23% of extra-EU exports of candles), Norway (€41 million, 22%), and the United States (€34 million, 18%), followed by Russia (€9 million, 5%), China (€5 million, 3%), Iceland and Ukraine (each €4 million, 2%), and the United Arab Emirates (€3 million, 2%).

The soy wax type segment is estimated to register the fastest CAGR from 2021 to 2028 due to the high demand for soy wax candles as they are completely plant-based, which makes them a renewable resource. A lot of consumers are abstaining from consuming any animal products. Most soy wax candles are made without the use of stearic acid (animal-based), which is used to harden the wax. Soy wax is derived from soybean. It is a hydrogenated vegetable that solidifies at room temperature. Soy wax does not contain anything artificial, which makes it a better alternative to paraffin wax. These factors are expected to boost the segment growth over the forecast years.

The online distribution channel segment is estimated to record the fastest CAGR from 2021 to 2028. Online channels include aggregators as well as manufacturer-hosted e-commerce sites. Manufacturers have realized the potential of online sales channels and thus, host their shopping websites to better cater to rising demand and improve profit margins. Third-party sellers sell products of major manufacturers as well as local producers. They excel by establishing a strong supply chain that extends geographical borders. Thus, when customers want to buy from international players that might not be available in a certain country, third-party suppliers offer the perfect solution.

Request a free sample copy or view report summary: Europe, Middle East & Africa Outdoor Candle Market Report

Europe, Middle East & Africa Outdoor Candle Market Report Highlights

• The overall market is expected to register a CAGR of 3.9% from 2021 to 2028
• The paraffin wax type segment accounted for the largest share of over 75.0% in 2020 and is expected to expand at a CAGR of 4.0% over the forecast period of 2021 to 2028
• However, the soy wax segment is expected to record the fastest CAGR over the forecast period
• The offline distribution channel segment accounted for the largest revenue share of more than 79.4% in 2020
• Germany led the overall market accounting for the largest revenue share of over 25.0% in 2020

Access Press Release@ https://www.grandviewresearch.com/press-release/emea-outdoor-candle-market-analysis

Europe, Middle East & Africa Outdoor Candle Market Segmentation

Grand View Research has segmented the Europe, Middle East & Africa outdoor candle market on the basis of wax type, distribution channel, and country:

EMEA Outdoor Candle Wax Type Outlook (Revenue, USD Million, 2016 - 2028)

• Paraffin Wax
• Soy Wax
• Bees Wax
• Palm Wax
• Others

EMEA Outdoor Candle Distribution Channel Outlook (Revenue, USD Million, 2016 - 2028)

• Online
• Offline

EMEA Outdoor Candle Country Outlook (Revenue, USD Million, 2016 - 2028)

• Germany
• UK.
• France
• South Africa

List of Key Players of Europe, Middle East & Africa Outdoor Candle Market

• The White Company
• Stennah & Hope Ltd.
• Scent Perfique
• Duffy and Scott Candlemakers Ltd.
• Engles Kerzen
• Gala Group GmBH

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Capnography Devices Market Precise Analysis on Business Overview, Product Scope And Ongoing Market Development

 Capnography Devices Market Growth & Trends

The global capnography devices market size is expected to reach USD 1.1 billion by 2028, according to a new study by Grand View Research, Inc. The market is expected to expand at a CAGR of 9.7% from 2021 to 2028. Introduction of regulatory guidelines for procedural sedation and growing adoption of capnography in patient monitoring due to higher reliability and efficiency are anticipated to propel market growth over the forecast period. In addition, associated advantages such as ease of usage, minimally invasive nature, and medical efficiency with its usage are the key growth drivers for the market. Moreover, rising incidences of respiratory diseases that need continuous patient monitoring are expected to fuel the demand for EtCO2 monitors in coming years.

The COVID-19 pandemic had a positive impact on the market as companies such as Medtronic witnessed increased demand for EtCO2 monitors during the pandemic. Some companies such as Capsule Technologies also received product approvals for their EtCO2 monitors during the pandemic, which further resulted in positive market growth.

The market is highly competitive in nature and a limited number of players have a high level of dominance over the overall revenue share. The key market players account for a considerable share owing to their product offerings. Market leaders are involved in the establishment of extensive distribution systems as well as increasingly involving in mergers and acquisitions to capture a larger share of the market. For instance, in January 2021, Koninklijke Philips N.V. announced the acquisition of Capsule Technologies, Inc., hence enhancing its position in the patient care management solutions for hospitals.

Request a free sample copy or view report summary: Capnography Devices Market Report

Capnography Devices Market Report Highlights

• The handheld capnography segment dominated the market in 2020, owing to associated benefits such as portability, light-weighted, ease of use, and treatment efficiency
• The microstream segment is expected to witness the fastest CAGR of 10.4% over the forecast period. This growth can be attributed to the fact that this technology is more effective and easier to incorporate as compared to sidestream and mainstream technology
• The emergency medicine segment dominated the market in 2020 owing to its usage to optimize pre-hospital ventilation, correct pediatric emergencies, and as a prognostic indicator to maintain pulmonary blood flow
• In Asia Pacific, the market is anticipated to register rapid growth in coming years owing to the presence of high unmet needs coupled with increasing patient awareness levels and improving healthcare infrastructure
• The hospital segment dominated the market in 2020 owing to the shifting preference of hospitals from conventional patient monitoring devices to capnographs
• Moreover, stringent norms for product approval and post-approval performance monitoring which are regulated by authorities such as the U.S. FDA and American Academy of Implant may act as a threat for new participants

Access Press Release@ https://www.grandviewresearch.com/press-release/global-capnography-device-market

Capnography Devices Market Segmentation

Grand View Research has segmented the global capnography devices market by component, application, product, technology, end-use, and region:

Capnography Devices Component Outlook (Revenue, USD Million, 2016 - 2028)

• OEM Modules
  • Infrared Sources
  • Others
• Others

Capnography Devices Product Outlook (Revenue, USD Million, 2016 - 2028)

• Handheld
• Standalone
• Multiparameter

Capnography Devices Technology Outlook (Revenue, USD Million, 2016 - 2028)

• Mainstream
• Sidestream
• Microstream

Capnography Devices Application Outlook (Revenue, USD Million, 2016 - 2028)

• Emergency Medicine
• Pain Management
• Procedural Sedation
• Critical Care
• Others

Capnography Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospitals
• Ambulatory Care Centers
• Others

Capnography Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa  
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Capnography Devices Market

• Masimo
• Smiths Medical, Inc.
• Dragerwerk AG & Co. KGaA
• Welch Allyn (Hill-Rom Holdings, Inc.)
• Koninklijke Philips N.V.
• Medtronic
• Nonin Medical, Inc.
• Nihon Kohden Corporation
• BD
• Diamedica (UK) Limited
• Edan Instruments, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Turkey Automotive Plastic Compounding Market Witness Excellent Revenue Growth During the Forecast Period

 

Turkey Automotive Plastic Compounding Market Growth & Trends

The Turkey automotive plastic compounding market size is anticipated to reach USD 451.3 million by 2028, according to a new report by Grand View Research, Inc., growing at a CAGR of 5.8% over the forecast period. According to Automotive Distributors Association (ODD), owing to the support of marketing campaigns and easing of lockdown measures, light commercial vehicles and passenger car sales jumped by 60% year-on-year in July 2020. The demand for automotive vehicles in the country is expected to steadily rise, which, in turn, is projected to fuel the plastic compounding market in Turkey.

Rising environmental awareness among the consumers and stringent regulations regarding pollution control have compelled automotive original component manufacturers to control automotive emissions by utilizing innovative lightweight materials. Car weight reduction is one surefire method of achieving carbon emission savings as weight reduction drastically boosts fuel efficiency and eliminates pollution to a large extent. Thus, plastic compounds of various chemistries are being utilized in several automotive interior & exterior components to ensure lower carbon emission levels.

Amid the COVID-19 crisis, the decline in demand was observed in the manufacturing sector of Turkey in Mid-March of 2020. The country’s automotive exports decreased by 30%. Similarly, the demand for plastic compounding decreased. Automotive companies in Turkey suspended their production activities. The demand for automotive declined as consumers were concerned about meeting their basic needs in the crisis. As the main markets for the Turkish automotive industry are European countries and about 75% of automotive production is sold in the European market, the production of automotive plastics and OEMs was negatively impacted by the decreasing domestic and foreign demand.

Request a free sample copy or view report summary: Turkey Automotive Plastic Compounding Market Report

Turkey Automotive Plastic Compounding Market Report Highlights

• Polypropylene (PP) was the largest product segment in 2020. PP resins have become an essential ingredient for lightweight impact-resistant automotive parts on account of the lower specific gravity of PP resins, which provides improved fuel economy and low emission
• The Interior component was the largest application segment in 2020. The rising demand for lightweight interior components to reduce the overall vehicle weight and enhance efficiency is driving the demand for automotive plastic compounding in the interior application
• Exterior fascia to emerge as the fastest-growing application segment owing to rising demand for energy management technologies that impede roof crush, resist vehicle intrusion, and lower overall car body weight without compromising on safety or performance

Access Press Release@ https://www.grandviewresearch.com/press-release/turkey-automotive-plastic-compounding-market-analysis

Turkey Automotive Plastic Compounding Market Segmentation

Grand View Research has segmented the Turkey automotive plastic compounding market based on product and application:

Turkey Automotive Plastic Compounding Product Outlook (Volume, Kilotons; Revenue, USD Million, 2016 - 2028)

• Acrylonitrile butadiene styrene (ABS)
• Polypropylene (PP)
• Polyurethane (PU)
• Polyvinyl Chloride (PVC)
• Polyethylene (PE)
• Polycarbonate (PC)
• Polyamide (PA)
• Thermoplastic Elastomer (TPE)
• Others

Turkey Automotive Plastic Compounding Application Outlook (Volume, Kilotons; Revenue, USD Million, 2016 - 2028)

• Instrument Panels
• Powertrain
• Door Systems
• Interior Components
• Exterior Fascia
• Under-the-hood
• Others

List of Key Players of Turkey Automotive Plastic Compounding Market

• EPSAN
• LANXESS
• PolyOne Corporation
• LyondellBasell Industries Holdings B.V.
• SABIC

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Meat Extract Market Size Projected to Rise Lucratively during 2021 to 2028: Grand View Research Inc.

 Meat Extract Market Growth & Trends

The global meat extract market size is expected to reach USD 21.72 billion by 2028, registering a CAGR of 5.2% over the forecast period, according to a new report by Grand View Research, Inc. The increasing health consciousness among consumers coupled with growing awareness about the importance of protein-rich diets is expected to propel the product demand over the forecast period.

The R&D initiatives undertaken by industry players leading to market development powered by economic growth in the developing countries will support market growth. Meat extracts have various applications in the food industry including ready meals, soups, sauces, soup powders, coatings, and seasoning; these applications are increasing both in number and volume as the food industry is introducing new products and expanding into emerging markets.

The beef, chicken, and pork type segments accounted for more than 88% of the global volume share in 2020 and are expected to retain similar market capitalization over the forecast period. This growth is credited to the high acceptance and consumption of meats by consumers across the globe. The demand for beef extracts is expected to increase due to the increasing use of the meat to enhance the nutritional value of the products, as it contains nucleotides, minerals & vitamins, organic acids, and amino acids & peptides.

North America was the dominant region in 2020 and is expected to retain its position over the forecast period on account of increased consumption of convenience & Ready-To-Eat (RTE) meals. Asia Pacific is expected to be the fastest-growing regional market over the forecast period as a result of the westernization of diets, rising disposable income levels, and rapid urbanization in emerging economies, such as India and China. The rising focus on leading a healthy and active lifestyle is boosting the sales of products that include meat extracts, which is also boosting the regional market growth.

The market participants are both backward and forward integrated, with involvement in the value chain from buying the meat to manufacturing extracts and utilizing them in various food products. For instance, the Knorr brand owned by Unilever sells beef extracts, as well as utilizes the same in its food products including meal mixes and dehydrated soups.

Request a free sample copy or view report summary: Meat Extract Market Report

Meat Extract Market Report Highlights

• The chicken type segment led the market, in terms of volume, in 2020 due to its easy availability and low cost of production
• However, beef ranked the highest, in terms of revenue, in 2020 due to increased global demand
• Based on form, the market is segmented into powder, paste, liquid, and granules. The paste segment is estimated to register the fastest CAGR from 2021 to 2028
• This is due to its rising use in various food products, such as pot pies, casseroles, sauces, and stews. Moreover, it is also widely used in commercial food chain restaurants and therefore is expected to have a consistently high demand without any major fluctuations
• The industrial application segment, which includes the product usage as flavor and nutrition additive during the production of processed foods, and also in microbial culture as growth promotor, accounted for more than 80% of the overall revenue share in 2020
• Asia Pacific is expected to be the fastest-growing regional market over the forecast period
• Central & South America is estimated to register the second-fastest CAGR during the forecast years due to high meat consumption coupled with large-scale beef production and exports in the region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-meat-extracts-market

Meat Extract Market Segmentation

Grand View Research has segmented the global meat extract market on the basis of type, form, application, and region:

Meat Extract Type Outlook (Revenue, USD Million; Volume, Kilotons, 2017 - 2028)

• Chicken
• Pork
• Beef
• Fish
• Turkey
• Others

Meat Extract Form Outlook (Revenue, USD Million; Volume, Kilotons, 2017 - 2028)

• Powder
• Paste
• Liquid
• Granules

Meat Extract Application Outlook (Revenue, USD Million; Volume, Kilotons, 2017 - 2028)

• Industrial
• Commercial

Meat Extract Regional Outlook (Revenue, USD Million; Volume, Kilotons, 2017 - 2028)

• North America
  • US. 
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
  • Italy
• Asia Pacific
  • China
  • India
  • Japan
• Central & South America (CSA)
  • Brazil
• Middle East & Africa (MEA)

List of Key Players of Meat Extract Market

• Givaudan
• Nikken Foods
• Essentia Protein Solutions
• IDF
• Haco Holding AG
• CHIMAB S.p.A.
• Foodex Inti Ingredients, PT
• Titan Biotech Ltd.
• Carnad A/S
• JBS S.A.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.